While attention-deficit/hyperactivity disorder (ADHD) was historically recognized as primarily a pediatric disorder, it is now recognized as a chronic often lifelong disorder. The previous few decades have seen an increasing number of adult patients seeking ADHD evaluation and treatment. Despite being associated with negative outcomes, many individuals may go untreated due to under- and misdiagnosis. The national stimulant shortage, which began in the Fall of 2022, is driven by many factors. This program will discuss how psychiatric pharmacists can evaluate ADHD in adults, create treatment plans, and identify treatment alternatives.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Faculty Information
View biographical information
Dr. Wells graduated from Butler University and went on to complete a PGY-1 Pharmacy Practice Residency at the VA in Houston, TX and PGY-2 Psychiatric Pharmacy Residency with Purdue University and Wishard Health Services in Indianapolis, IN. Dr. Wells completed her MBA in 2019 from St. Mary's College of California and is board certified in Psychiatric Pharmacy (BCPP). She started her career as a Mental Health Clinical Pharmacy Practitioner at the VA in Columbia, SC working in outpatient mental health. Then moved on to serve as an Academic Detailer for the VISN 21/22 Academic Detailing Pilot Program. In 2015, she became an Education & Training Clinical Program Manager for PBM Academic Detailing Services (ADS) supporting education, training, and program implementation across VHA. In 2022, Dr. Wells accepted the position of Assistant Chief Consultant, PBM, ADS Education and Training and works out of the Seattle, WA area.
For more than 10 years, Dr. Wells has served as lead author for national educational materials on mental health disorders including ADHD, Insomnia Disorder, Opioid Use Disorder, Stimulant Use Disorder, and Treatment-resistant Depression. She currently serves as Co-Chair for the VHA Office of Mental Health and Suicide Prevention ADHD Workgroup and a member of the “Ask the Expert – ADHD” email consultation service for VHA.
Learning Objectives
- Evaluate adult patients for attention-deficit/hyperactivity disorder (ADHD) using screening tools and rating scales.
- Formulate treatment plans for adult patients with ADHD.
- Identify appropriate stimulant medication alternatives during a medication shortage.
Continuing Education Credit and Disclosures
Activity Dates: 10/11/2024 - 10/10/2027
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-24-062-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.